MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Acelia Pharma reported its Q4 2024 earnings, focusing on its strategic advancements and financial stability. The company announced an operating loss of 21.9 million kronor, while maintaining a cash ...